ברקלוד 1 מ"ג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

ENTECAVIR 1 MG

Commercializzato da:

BRISTOL, MYERS SQUIBB (ISRAEL) LIMITED

Codice ATC:

J05AF10

Forma farmaceutica:

FILM COATED TABLETS

Via di somministrazione:

PER OS

Prodotto da:

BRISTOL MYERS SQUIBB SPA, ITALY

Gruppo terapeutico:

ENTECAVIR

Indicazioni terapeutiche:

Baraclude is indicated for the treatment of chronic hepatitis B virus (HBV) infection in adults with compensated liver disease and evidence of active viral replication, and persistently elevated serum alanine aminotransferase (ALT) levels. This indication is based on clinical trial data in patients with HBeAg positive and HBeAg negative HBV infection, nucleoside naive patients and patients with lamivudine-refractory hepatitis B.Decompensated liver disease.

Data dell'autorizzazione:

2009-02-01